C5b-C9 Deficiency
Author:
Grumach Anete Sevciovic
Publisher
Springer New York
Reference58 articles.
1. Andreoni J, Käyhty H, Densen P. Vaccination and the role of capsular polysaccharide antibody in prevention of recurrent meningococcal disease in late complement component-deficient individuals. J Infect Dis. 1993;168:227–31.
2. Arnold DF, Roberts AG, Thomas A, Ferry B, Morgan BP, Chapel HA. Novel mutation in a patient with a deficiency of the eighth component of complement associated with recurrent meningococcal meningitis. J Clin Immunol. 2009;29:691–5.
3. Barilla-LaBarca ML, Atkinson JP. Rheumatic syndromes associated with complement deficiency. Curr Opin Rheumatol. 2003;15:55–60.
4. Bols A, Janssens J, Petermans W, Stevens E, Bobbaers H. Recurrent meningococcal infections in a patient with congenital C5 deficiency. Acta Clin Belg. 1993;48(10):42–7.
5. Brandtzaeg P, Mollnes TE, Kierulf P. Complement activation and endotoxin levels in systemic meningococcal disease. J Infect Dis. 1989;160:58–65.